NH
New Hampshire House Bill HB1501

New Hampshire 2022 Regular Session

New Hampshire House Bill HB1501

Introduced
12/3/21  

Caption

Relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

Impact

The impact of this bill on state laws is significant as it upholds statutory requirements for insurance providers to cover treatments linked to pediatric autoimmune neuropsychiatric disorders. This is particularly important in a landscape where insurance modifications could restrict access to crucial therapies. The bill reinforces the state's commitment to providing consistent coverage without allowing insurances to impose limitations that could adversely affect pediatric patients and their families.

Summary

House Bill 1501 aims to maintain existing insurance coverage for pediatric autoimmune neuropsychiatric disorders by repealing a prospective modification set to take effect in 2024. This modification would have removed critical language from current law, specifically concerning the use of intravenous immunoglobulin therapy as part of the treatment protocol. By ensuring that coverage remains intact, the bill seeks to safeguard access to necessary medical treatments for affected children.

Sentiment

The general sentiment around HB 1501 appears to be supportive, especially among advocates for pediatric health and mental health services. Supporters could view this bill as a necessary measure to protect vulnerable patients who rely on these services. However, some stakeholders might express concerns about financial implications, predicting that maintaining comprehensive coverage could potentially lead to increased premiums.

Contention

Notable points of contention may arise regarding the projected financial implications of this bill. The Insurance Department indicated that they could not determine the exact impact on claims costs, indicating a level of uncertainty regarding how insurers will adjust their premium pricing or coverage structures in light of the bill. While maintaining coverage is beneficial for public health, the potential economic burdens on the insurance market remain a topic of debate.

Companion Bills

No companion bills found.

Previously Filed As

NH HB1094

Relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

NH HB820

Health Insurance - Pediatric Autoimmune Neuropsychiatric Disorders - Modification of Coverage Requirements

NH SB205

Insurance; pediatric autoimmune neuropsychiatric disorders; require coverage for healthcare services

NH HB124

Insurance; require coverage for healthcare services for pediatric autoimmune neuropsychiatric disorders; provisions

NH HB2824

Mandating insurance coverage for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).

NH HB2087

In casualty insurance, providing for coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

NH HB1437

Insurance; require coverage for diagnosis and treatment of pediatric autoimmune neuropsychiatric disorders; provisions

NH SF288

A bill for an act relating to health insurance coverage for specified pediatric autoimmune neuropsychiatric disorders and postinfectious autoimmune encephalopathy.

NH LD663

An Act to Require Health Insurance Coverage for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections and Pediatric Acute-onset Neuropsychiatric Syndrome

NH SF242

A bill for an act relating to health insurance coverage for specified pediatric autoimmune neuropsychiatric disorders and postinfectious autoimmune encephalopathy.

Similar Bills

No similar bills found.